# K133938: Endo Gia Reinforced Reload with Tri-Staple Technology

- Pathway: 510(k) (Special)
- Applicant: Covidien
- Decided: Jan 22, 2014 after 30 days
- Product code: GDW (Staple, Implantable)
- Device class: 2
- Regulation: 21 CFR 878.4750
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 11 generations back to K842066 (1985). 66 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 68 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K111825: Endo Gia (TM) Staplers, DST Series (TM) Gia (TM) Staplers, DST Series (TM) TA (TM) Staplers, Covidien, Formerly US Surgical A Divison of Tyco H (2011)
- K130997: Neoveil, Gunze Limited (2013) Summary page 1.

## Most influential descendants
- K173270: Tri-Staple 2.0 Reinforced Reload (2018), 0 descendants of its own

## Indications for use
Endo GIA™ reinforced reload with Tri-Staple™ Technology preloaded with polyglycolic acid staple line reinforcement has applications in abdominal, gynecologic, pediatric and thoracic surgery for resection, transection of tissue and creation of anastomosis. They may be used for transection and resection of liver substance, hepatic vasculature and biliary structures, and for transection and resection of pancreas.

Source page: https://510kreport.com/device/K133938
Methodology: https://510kreport.com/methodology